News | News By Subject | News by Disease News By Date | Search News

Herpes labialis (oral Herpes simplex) News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Three Cancer Drugs are Up for FDA Approval in October     9/28/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
BioAlliance Pharma Announces Positive Preliminary Pivotal Phase III Results in Herpes Labialis with Acyclovir Lauriad(R)     8/26/2009
Renovis, Inc. (RNVS) Drug Fails Mid-Stage Trial     3/8/2005
Flamel Technologies (FLML) Announces Termination Of Licensing Agreement With Biovail Laboratories Inc. For Genvir And Recovery Of Rights     3/4/2005
PRO 2000, Under Development By Indevus Pharmaceuticals, Inc., (IDEV) Shown To Inhibit HIV And Herpes Simplex Virus Infection Following Human Administration     2/25/2005
Transport Pharmaceuticals Announces Agreement With GlaxoSmithKline (GSK) For European Rights To A Device/Drug Combination System For High-Potency Delivery Of Acyclovir     1/27/2005

News from Around the Web
Herpes Virus Changes Anti-Herpes Drug to Form that Hinders AIDS Virus, National Institutes of Health (NIH) Study     9/11/2008
Second Study Finds Treating Herpes Won't Stop HIV, London School of Hygiene and Tropical Medicine Study     3/13/2008
Novel Vaccine Concept Developed By Scientists At The Wistar Institute     1/31/2008
HealthWrap: Herpes Linked To Alzheimer's     1/4/2007
Study Shows How Herpes Infects Cornea, Evades immune cells     9/25/2006
Experimental Vaginal Gel Inhibits HIV And HSV     1/24/2006
FDA Proposes Easing Rules On Herpes Tests     1/9/2006
Liquorice Stops "Herpes" Cancer     3/2/2005
Study To Pit Herpes Drug Against HIV     12/2/2004
Cranberries "Could Treat Herpes"     10/18/2004
Herpes Tool Allows Researchers To Customize Alzheimer's Vaccine     6/30/2004
Researchers Discover Cold Virus Can "Hit And Hide"     4/26/2004

Press Releases
Aethlon Medical (AEMD) Reports Results Of Cytomegalovirus, Epstein-Barr And Herpes Simplex Virus Studies     2/22/2017
Flawed Herpes Testing Leads To Many False Positives — And Needless Suffering     1/26/2017
AiCuris Release: Pharma Announces Publication Of Phase 2 Clinical Trial Results Of Investigational Anti-Herpes Simplex Virus Agent Pritelivir In JAMA     1/17/2017
Rational Vaccines Release: First Ever Human Trial Of A Live Attenuated Functioning Therapeutic Herpes Vaccine     10/17/2016
N&N Pharma Release: N-Methanocarbathymidine Granted Orphan Drug Designation In The U.S.     9/27/2016
NanoViricides, Inc. (NNVC.PK) Signs Agreement For Ocular Testing Of Its Drug Candidates For The Treatment Of Herpes Keratitis With The University of Pittsburgh     2/11/2016
Genocea Biosciences Reports Second Quarter 2015 Financial Results     8/6/2015
BioAlliance Pharma's Sitavig® Receives Market Authorization in the U.S. for the Treatment of Herpes Labialis     4/16/2013
NanoBio Corporation and GlaxoSmithKline (GSK) Commence Phase 3 Studies of Nanoemulsion-based OTC Treatment for Cold Sores     5/11/2011
BioAlliance Pharma Presents the Results of an International Survey Performed With Nielsen in Patients Suffering from Herpes Labialis     2/7/2011
Medivir AB (MVIRb.F)'s U.S. Commercialisation Partner Meda Presents Positive Xerese(TM) Data at ASHP     12/8/2010
New American Therapeutics Acquires Antiviral Drug Denavir(R)     10/4/2010
BioAlliance Pharma: Acyclovir Lauriad(R): US Registration File Submission Planned End-2011     8/26/2010
NanoBio Corporation Awarded New Patent Covering its Nanoemulsion-Based Anti-Infective Product Candidate for the Treatment of Cold Sores     8/3/2010
FDA Approves Beech Tree Labs, Inc.'s Oral Herpes IND Application     7/7/2010